These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16322279)

  • 21. The application of new knowledge to the effective administration of anticancer agents.
    Nichol CA
    Cancer Res; 1969 Dec; 29(12):2469-70. PubMed ID: 5369693
    [No Abstract]   [Full Text] [Related]  

  • 22. Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs.
    Lacko AG; Nair M; Prokai L; McConathy WJ
    Expert Opin Drug Deliv; 2007 Nov; 4(6):665-75. PubMed ID: 17970668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of pH-sensitive liposomes retaining SOD mimic and their anticancer effect.
    Hiraka K; Kanehisa M; Tamai M; Asayama S; Nagaoka S; Oyaizu K; Yuasa M; Kawakami H
    Colloids Surf B Biointerfaces; 2008 Nov; 67(1):54-8. PubMed ID: 18775654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AACR-NCI-EORTC--19th symposium. Molecular Targets and Cancer Therapeutics--Part 3.
    Collins T
    IDrugs; 2007 Dec; 10(12):840-3. PubMed ID: 18041675
    [No Abstract]   [Full Text] [Related]  

  • 25. Nanoparticles for delivery of chemotherapeutic agents to tumors.
    Vijayaraghavalu S; Raghavan D; Labhasetwar V
    Curr Opin Investig Drugs; 2007 Jun; 8(6):477-84. PubMed ID: 17621878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanopharmacology of liposomes developed for cancer therapy.
    Muthu MS; Feng SS
    Nanomedicine (Lond); 2010 Sep; 5(7):1017-9. PubMed ID: 20874016
    [No Abstract]   [Full Text] [Related]  

  • 27. An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells.
    Chen C; Johnston TD; Jeon H; Gedaly R; McHugh PP; Burke TG; Ranjan D
    Int J Pharm; 2009 Jan; 366(1-2):133-9. PubMed ID: 18840516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active targeting schemes for nanoparticle systems in cancer therapeutics.
    Byrne JD; Betancourt T; Brannon-Peppas L
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1615-26. PubMed ID: 18840489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid composition and grafted PEG affect in vivo activity of liposomal mitoxantrone.
    Li C; Cui J; Wang C; Wang J; Li Y; Zhang L; Zhang L; Guo W; Wang Y
    Int J Pharm; 2008 Oct; 362(1-2):60-6. PubMed ID: 18598745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular imaging as a tool for personalized and targeted anticancer therapy.
    McLarty K; Reilly RM
    Clin Pharmacol Ther; 2007 Mar; 81(3):420-4. PubMed ID: 17339871
    [No Abstract]   [Full Text] [Related]  

  • 31. [Anticancer chemotherapy at home].
    Durand M
    Rev Infirm; 1981 Nov; 31(17):29-32. PubMed ID: 6916395
    [No Abstract]   [Full Text] [Related]  

  • 32. Repeated injection of pegylated liposomal antitumour drugs induces the disappearance of the rapid distribution phase.
    Cui J; Li C; Wang C; Li Y; Zhang L; Zhang L; Yang H
    J Pharm Pharmacol; 2008 Dec; 60(12):1651-7. PubMed ID: 19000370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Practical rules of the administration and complications of anticancer drugs].
    Pouillart P
    Rev Prat; 1981 Oct; 31(43):2999-3002 passim. PubMed ID: 7291907
    [No Abstract]   [Full Text] [Related]  

  • 34. Combination of combretastatin A4 phosphate and doxorubicin-containing liposomes affects growth of B16-F10 tumors.
    Mitrus I; Sochanik A; CichoĊ„ T; Szala S
    Acta Biochim Pol; 2009; 56(1):161-5. PubMed ID: 19287800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.
    Wang D; Veena MS; Stevenson K; Tang C; Ho B; Suh JD; Duarte VM; Faull KF; Mehta K; Srivatsan ES; Wang MB
    Clin Cancer Res; 2008 Oct; 14(19):6228-36. PubMed ID: 18829502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-cancer agents. Liposomal chemo for KS.
    TreatmentUpdate; 2008; 20(5):7-9. PubMed ID: 19248280
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice.
    Li X; Lu WL; Liang GW; Ruan GR; Hong HY; Long C; Zhang YT; Liu Y; Wang JC; Zhang X; Zhang Q
    Eur J Clin Invest; 2006 Jun; 36(6):409-18. PubMed ID: 16684125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermosensitive liposomes.
    Woo J; Chiu GN; Karlsson G; Wasan E; Ickenstein L; Edwards K; Bally MB
    Int J Pharm; 2008 Feb; 349(1-2):38-46. PubMed ID: 17728083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Release profile of compound liposomes entrapped with vincristine sulfate and mitoxantrone chlorhydric acid in vitro and their distribution in mice].
    Chen T; Hou SX; Wang YY; Zhang WS; Chen DH
    Yao Xue Xue Bao; 2006 Dec; 41(12):1170-5. PubMed ID: 17290615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanistic study of the sPLA2-mediated hydrolysis of a thio-ester pro anticancer ether lipid.
    Linderoth L; Fristrup P; Hansen M; Melander F; Madsen R; Andresen TL; Peters GH
    J Am Chem Soc; 2009 Sep; 131(34):12193-200. PubMed ID: 19663381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.